These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23168260)

  • 1. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.
    Mallette FA; Richard S
    Cell Rep; 2012 Nov; 2(5):1233-43. PubMed ID: 23168260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.
    Kim TD; Shin S; Berry WL; Oh S; Janknecht R
    J Cell Biochem; 2012 Apr; 113(4):1368-76. PubMed ID: 22134899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
    Berry WL; Shin S; Lightfoot SA; Janknecht R
    Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells.
    Neault M; Mallette FA; Richard S
    Cell Rep; 2016 Mar; 14(8):1966-78. PubMed ID: 26904954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved antagonism between JMJD2A/KDM4A and HP1γ during cell cycle progression.
    Black JC; Allen A; Van Rechem C; Forbes E; Longworth M; Tschöp K; Rinehart C; Quiton J; Walsh R; Smallwood A; Dyson NJ; Whetstine JR
    Mol Cell; 2010 Dec; 40(5):736-48. PubMed ID: 21145482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
    Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
    Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHD5 is a tumor suppressor at human 1p36.
    Bagchi A; Papazoglu C; Wu Y; Capurso D; Brodt M; Francis D; Bredel M; Vogel H; Mills AA
    Cell; 2007 Feb; 128(3):459-75. PubMed ID: 17289567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction.
    Takaoka M; Harada H; Deramaudt TB; Oyama K; Andl CD; Johnstone CN; Rhoades B; Enders GH; Opitz OG; Nakagawa H
    Oncogene; 2004 Sep; 23(40):6760-8. PubMed ID: 15273725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
    Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
    J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cellular senescence by oncogenic RAS.
    Gupta R; Wajapeyee N
    Methods Mol Biol; 2013; 1048():127-33. PubMed ID: 23929102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN E.
    Vredeveld LC; Rowland BD; Douma S; Bernards R; Peeper DS
    Carcinogenesis; 2010 Feb; 31(2):201-7. PubMed ID: 19942610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition.
    Kogure M; Takawa M; Cho HS; Toyokawa G; Hayashi K; Tsunoda T; Kobayashi T; Daigo Y; Sugiyama M; Atomi Y; Nakamura Y; Hamamoto R
    Cancer Lett; 2013 Aug; 336(1):76-84. PubMed ID: 23603248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of CSN5 inhibits Ras-mediated tumorigenesis by inducing premature senescence in p53-null cells.
    Tsujimoto I; Yoshida A; Yoneda-Kato N; Kato JY
    FEBS Lett; 2012 Dec; 586(24):4326-31. PubMed ID: 23127558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.
    Zhao R; Yan Q; Lv J; Huang H; Zheng W; Zhang B; Ma W
    Lung Cancer; 2012 Jun; 76(3):324-31. PubMed ID: 22186629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer.
    Li W; Zhao L; Zang W; Liu Z; Chen L; Liu T; Xu D; Jia J
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):372-8. PubMed ID: 22133676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
    Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
    Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.
    Johmura Y; Sun J; Kitagawa K; Nakanishi K; Kuno T; Naiki-Ito A; Sawada Y; Miyamoto T; Okabe A; Aburatani H; Li S; Miyoshi I; Takahashi S; Kitagawa M; Nakanishi M
    Nat Commun; 2016 Feb; 7():10574. PubMed ID: 26868148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the p53 response to oncogene-induced senescence.
    Ruiz L; Traskine M; Ferrer I; Castro E; Leal JF; Kaufman M; Carnero A
    PLoS One; 2008 Sep; 3(9):e3230. PubMed ID: 18800172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.